Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 2/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.52 |
| ▸ | MAOB | P27338 | 5/20 | 0.50 |
| ▸ | OSBP | P22059 | 1/20 | 0.50 |
| ▸ | PPARG | P37231 | 6/20 | 0.49 |
| ▸ | PPARA | Q07869 | 5/20 | 0.49 |
| ▸ | APP | P05067 | 2/20 | 0.49 |
| ▸ | PTGES | O14684 | 1/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
| ▸ | INHA | P05111 | 1/20 | 0.46 |
| ▸ | CNR1 | P21554 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.46 |
| ▸ | CNR2 | P34972 | 1/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cymopol SCHEMBL21055681 | 1.00 | BACE1 (0.52) | BACE1PTPN1MAOBOSBPPPARG | |
| Cymopol SCHEMBL8649278 | 1.00 | BACE1 (0.52) | BACE1PTPN1MAOBOSBPPPARG | |
| SCHEMBL9714237 | 0.91 | PTPN1 (0.61) | BACE1PTPN1MAOBOSBPPPARG | |
| SCHEMBL9714250 | 0.91 | PTPN1 (0.61) | BACE1PTPN1MAOBOSBPPPARG | |
| SCHEMBL7135772 | 0.83 | BACE1 (0.57) | BACE1PTPN1MAOBOSBPPPARG | |
| SCHEMBL7080850 | 0.82 | MAOB (0.63) | BACE1PTPN1MAOBOSBPPPARG | |
| SCHEMBL7048803 | 0.82 | MAOB (0.63) | BACE1PTPN1MAOBOSBPPPARG | |
| SCHEMBL5820932 | 0.78 | APP (0.52) | BACE1PTPN1MAOBOSBPPPARG | |
| SCHEMBL21055687 | 0.77 | CYP1A1 (0.58) | BACE1PTPN1OSBP | |
| SCHEMBL21055680 | 0.77 | CYP1A1 (0.58) | BACE1PTPN1OSBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240226211-A9 | SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2024-07-11 | — | — | US | claimed |
| US-20240131097-A1 | SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2024-04-25 | — | — | US | claimed |
| US-12102653-B2 | Ligand regulated protein-protein interaction system | ST. ANNA KINDERKREBSFORSCHUNG (AT) | 2024-10-01 | — | — | US | disclosed |
| US-20240226211-A9 | SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2024-07-11 | — | — | US | disclosed |
| US-20240131097-A1 | SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2024-04-25 | — | — | US | disclosed |
| US-20240000841-A1 | LIGAND REGULATED PROTEIN-PROTEIN INTERACTION SYSTEM | ST ANNA KINDERKREBSFORSCHUNG (AT) | 2024-01-04 | — | — | US | disclosed |
| US-11844813-B2 | Ligand regulated protein-protein interaction system | ST. ANNA KINDERKREBSFORSCHUNG (AT) | 2023-12-19 | — | — | US | disclosed |
| US-20220041687-A1 | A GROUP OF CHIMERIC ANTIGEN RECEPTORS (CARS) | ST. ANNA KINDERKREBSFORSCHUNG (AT) | 2022-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240131097-A1 | SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT | KEAP1, NFE2L2, TFEB | BACE1 133/4885PTPN1 4535/4885MAOB 3470/4885 |
| US-20220041687-A1 | A GROUP OF CHIMERIC ANTIGEN RECEPTORS (CARS) | CARS1, CD74, HAVCR2 | BACE1 3128/4885PTPN1 1563/4885MAOB 4846/4885 |
| US-20240226211-A9 | SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT | KEAP1, NFE2L2, TFEB | BACE1 133/4885PTPN1 4535/4885MAOB 3470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.